Skip to main content
Responses to parliamentary questions

Question from Deputy Cormac Devlin - PQ 30915-26

Deputy Devlin asked about an application received by the HSE for pricing and reimbursement of baricitinib. Read the HSE response.


Documents

Summary

To ask the Minister for Health if an application has been received by the HSE for pricing and reimbursement of baricitinib for the alopecia areata indication; if not, whether the HSE or her Department has engaged with the marketing authorisation holder regarding a submission (further to a previous PQ); and if she will make a statement on the matter.


This is a beta version - your feedback will help us to improve it

Question from Deputy Cormac Devlin - PQ 30915-26